Objective Many societies recommend using estimated glomerular filtration rate (eGFR) rather than serum creatinine (sCr) to determine metformin eligibility. We examined the potential impact of ...

Delphine S. Tuot; Feng Lin; Michael G. Shlipak; Vanessa Grubbs; Chi-yuan Hsu; Jerry Yee; Vahakn Shahinian; Rajiv Saran; Sharon Saydah; Desmond E. Williams; Neil R. Powe ...

The Food and Drug Administration (FDA) approved Metformin in 1994 to treat type 2 diabetes. It is generally used for diabetes that does not require insulin. Metformin is also currently the only ...

The good news? There isn’t a metformin diet plan you need to follow. The bad news? There isn’t a metformin diet plan to follow. That can feel overwhelming if you’re unsure where to start ...

In this article, we are going to take a look at where Greenfire Resources Ltd. (NYSE:GFR) stands against other energy stocks that are declining this week. The energy sector suffered a massive blow ...

Compared with the original placebo group, the median time without diabetes was extended by 3.5 years in the lifestyle group and 2.5 years in the metformin group. The original DPP clinical trial ...

“GPs [general practitioners] are very familiar with metformin, which is a low-cost, safe medication,” said the study’s corresponding author, Professor Flavia Cicuttini, Head of Rheumatology ...

Ozempic (semaglutide) and metformin are prescription drugs that are both used to help manage blood sugar levels in people with type 2 diabetes. Ozempic is a brand-name drug, while metformin is a ...

Metformin is one of the most widely prescribed drugs on the planet. An estimated 200 million people worldwide take it daily, primarily to treat or prevent Type 2 diabetes, according to UCHealth.

A 65-year-old woman presents to her primary care provider with a chief complaint of "feeling winded" for the last 3 weeks.